Cargando…

Sertraline treatment influences [(18)F]FE-PE2I PET imaging for Parkinsonism

BACKGROUND: The dopamine transporter (DaT) PET ligand [(18)F]FE-PE2I is used to aid the diagnosis of Parkinson’s disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [(18)F]FE-PE2I PET, we suspected that the selective serotonin reuptak...

Descripción completa

Detalles Bibliográficos
Autores principales:	Justesen, Thomas E. H., Borghammer, Per, Aanerud, Joel, Hovind, Peter, Marner, Lisbeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205964/ https://www.ncbi.nlm.nih.gov/pubmed/37221321 http://dx.doi.org/10.1186/s13550-023-01000-6

Ejemplares similares

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

Diagnostic accuracy of cerebral [(18)F]FDG PET in atypical parkinsonism
por: Houssein, Naba Jawad, et al.
Publicado: (2023)

Longitudinal DAT changes measured with [(18)F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
por: Kerstens, V.S., et al.
Publicado: (2023)

[(18)F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
por: Kerstens, Vera S., et al.
Publicado: (2023)

Simplified quantification of [(18)F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
por: Brumberg, Joachim, et al.
Publicado: (2020)

Fully Automated GMP-Compliant Synthesis of [(18)F]FE-PE2I
por: Bratteby, Klas, et al.
Publicado: (2021)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Validation of dynamic [(18)F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [(15)O]H(2)O PET
por: Jakobson Mo, Susanna, et al.
Publicado: (2022)

Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [(18)F]FE-PE2I
por: Nogami, Tsuyoshi, et al.
Publicado: (2022)

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [(18)F]FE-PE2I-OH for Translational Dopamine Transporter Imaging
por: Schou, Magnus, et al.
Publicado: (2023)

Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls — a Quantitative [(18)F]Fluoride PET Study
por: Fuglø, Dan, et al.
Publicado: (2023)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2020)

[(18)F]MPPF and [(18)F]FDG μPET imaging in rats: impact of transport and restraint stress
por: Buchecker, Verena, et al.
Publicado: (2020)

(82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison
por: Krakauer, Martin, et al.
Publicado: (2023)

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
por: Kjeldsen, Pernille L., et al.
Publicado: (2022)

Sertraline inhibits formalin-induced nociception and cardiovascular responses
por: Santuzzi, C.H., et al.
Publicado: (2011)

Initial evaluation of [(18)F]-FACBC for PET imaging of multiple myeloma
por: Morath, Volker, et al.
Publicado: (2022)

In vivo vesicular acetylcholine transporter density in human peripheral organs: an [(18)F]FEOBV PET/CT study
por: Horsager, Jacob, et al.
Publicado: (2022)

Utility of 18F FDG-PET in Parkinsonism in an African population
por: Amod, Ferzana Hassan, et al.
Publicado: (2022)

The effects of muscle exercise and bed rest on [(18)F]methylcholine PET/CT
por: Roef, Mark, et al.
Publicado: (2010)

Differences in Striatal Metabolism in [(18)F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism
por: Seiffert, Alexander P., et al.
Publicado: (2022)

(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)

Antibody-mediated autoimmune encephalitis evaluated by (18)F-DPA714 PET/MRI
por: Shen, Ruinan, et al.
Publicado: (2022)

Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [(18)F]FE-PE2I Positron Emission Tomography Analysis Study
por: Park, Hyun Soo, et al.
Publicado: (2020)

(18)F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
por: Wiegman, Erwin M., et al.
Publicado: (2011)

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using (18)F-fluorocholine PET/CT
por: van den Esschert, Jacomina W., et al.
Publicado: (2010)

Design and Synthesis of an (18)F-Labeled Version of Phenylethyl Orvinol ([(18)F]FE-PEO) for PET-Imaging of Opioid Receptors
por: Marton, János, et al.
Publicado: (2012)

The Gut and Parkinson’s Disease: Hype or Hope?
por: Scheperjans, Filip, et al.
Publicado: (2018)

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline
por: Borghammer, Per
Publicado: (2021)

PE and PET oligomers’ interplay with membrane bilayers
por: Järvenpää, Joni, et al.
Publicado: (2022)

Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
por: Sollini, Martina, et al.
Publicado: (2020)

Multivariate Analysis of (18)F-DMFP PET Data to Assist the Diagnosis of Parkinsonism
por: Segovia, Fermín, et al.
Publicado: (2017)

Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson’s disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Gastrointestinal Dysfunction in Parkinson’s Disease
por: Skjærbæk, Casper, et al.
Publicado: (2021)

PET Imaging of VMAT2 with the Novel Radioligand [(18)F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [(11)C]DTBZ and [(18)F]FE-DTBZ
por: Nag, Sangram, et al.
Publicado: (2021)

Initial investigation of (18)F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
por: Quon, Andrew, et al.
Publicado: (2012)

Simplifying [(18)F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential?
por: McGinnity, Colm J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2oe4fsppal4tt0v4ofd46itndo